Is AI drug discovery and development finally here?

In this episode of Our Own Devices, our host Nandagopal Rajan, CEO, The Indian Express Digital is joined by serial entrepreneur Soujanya Bhumkar, and Ritu Lal, CEO and Co-founder, GEn1E Lifesciences Inc. Today’s conversation centres around using AI for discovering and developing drugs at a fast pace. As far as the field of biotechnology is concerned, a major use case for artificial intelligence is discovering and developing personalised drugs that can help solve more specific conditions and diseases, or specified strains of different illnesses. To learn more about how this is being done, tune into Our Own Devices with Nandagopal Rajan.